Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence

E. Bertaglia, B. Blank, C. Blomström-Lundqvist, A. Brandes, N. Cabanelas, GA. Dan, W. Dichtl, A. Goette, JR. de Groot, A. Lubinski, E. Marijon, B. Merkely, L. Mont, C. Piorkowski, A. Sarkozy, N. Sulke, P. Vardas, V. Velchev, D. Wichterle, P. Kirchhof,

. 2019 ; 21 (10) : 1459-1467. [pub] 2019Oct01

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028801

Grantová podpora
FS/13/43/30324 British Heart Foundation - United Kingdom
PG/17/30/32961 British Heart Foundation - United Kingdom

Self-terminating atrial arrhythmias are commonly detected on continuous rhythm monitoring, e.g. by pacemakers or defibrillators. It is unclear whether the presence of these arrhythmias has therapeutic consequences. We sought to summarize evidence on the prevalence of atrial high-rate episodes (AHREs) and their impact on risk of stroke. We performed a comprehensive, tabulated review of published literature on the prevalence of AHRE. In patients with AHRE, but without atrial fibrillation (AF), we reviewed the stroke risk and the potential risk/benefit of oral anticoagulation. Atrial high-rate episodes are found in 10-30% of AF-free patients. Presence of AHRE slightly increases stroke risk (0.8% to 1%/year) compared with patients without AHRE. Atrial high-rate episode of longer duration (e.g. those >24 h) could be associated with a higher stroke risk. Oral anticoagulation has the potential to reduce stroke risk in patients with AHRE but is associated with a rate of major bleeding of 2%/year. Oral anticoagulation is not effective in patients with heart failure or survivors of a stroke without AF. It remains unclear whether anticoagulation is effective and safe in patients with AHRE. Atrial high-rate episodes are common and confer a slight increase in stroke risk. There is true equipoise on the best way to reduce stroke risk in patients with AHRE. Two ongoing trials (NOAH-AFNET 6 and ARTESiA) will provide much-needed information on the effectiveness and safety of oral anticoagulation using non-vitamin K antagonist oral anticoagulants in patients with AHRE.

Arrhythmias Unit of Cardiology Department Hospital Prof Dr Fernando Fonseca Amadora Sintra Portugal

Atrial Fibrillation NETwork Muenster Germany

Atrial Fibrillation NETwork Muenster Germany Institute of Cardiovascular Sciences University of Birmingham UHB and Sandwell and West Birmingham Hospitals NHS Trusts IBR 126a Wolfson Drive Birmingham B15 2TT UK

Atrial Fibrillation NETwork Muenster Germany St Vincenz Hospital Paderborn Cardiology and Intensive Care Medicine Paderborn Germany

Cardiac Electrophysiology Section European Georges Pompidou Hospital Paris France

Cardiology Clinic St Anna University Hospital Medical University Sofia Sofia Bulgaria

Cardiovascular Clinical Institute Hospital Clinic Universitat de Barcelona Catalonia Spain

Colentina University Hospital Medicine University Carol Davila Bucharest Romania

Department of Cardiac Vascular and Thoracic Sciences Azienda Ospedaliera Padua Italy

Department of Cardiology Heart Center Amsterdam University Medical Center University of Amsterdam Amsterdam the Netherlands

Department of Clinical Research University of Southern Denmark Odense Denmark Department of Cardiology Odense University Hospital Odense Denmark

Department of Interventional Cardiology and Arrhythmias Medical University of Lodz Lodz Poland

Department of Medical Science Uppsala University Uppsala Sweden

Eastbourne District General Hospital Eastbourne UK

Heart and Vascular Center Semmelweis University Budapest Budapest Hungary

Heart Sector Hygeia Group Hospitals Athens Greece

Herzzentrum Dresden GmbH Universitätsklinikum Dresden Germany

Institute for Clinical and Experimental Medicine Prague Czech Republic

Universitair Ziekenhuis Antwerpen Edegem Belgium

University Hospital of Internal Medicine 3 Medical University Innsbruck Innsbruck Austria

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028801
003      
CZ-PrNML
005      
20210114155157.0
007      
ta
008      
210105s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/europace/euz172 $2 doi
035    __
$a (PubMed)31377792
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Bertaglia, Emanuele $u Department of Cardiac, Vascular and Thoracic Sciences, Azienda Ospedaliera, Padua, Italy.
245    10
$a Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence / $c E. Bertaglia, B. Blank, C. Blomström-Lundqvist, A. Brandes, N. Cabanelas, GA. Dan, W. Dichtl, A. Goette, JR. de Groot, A. Lubinski, E. Marijon, B. Merkely, L. Mont, C. Piorkowski, A. Sarkozy, N. Sulke, P. Vardas, V. Velchev, D. Wichterle, P. Kirchhof,
520    9_
$a Self-terminating atrial arrhythmias are commonly detected on continuous rhythm monitoring, e.g. by pacemakers or defibrillators. It is unclear whether the presence of these arrhythmias has therapeutic consequences. We sought to summarize evidence on the prevalence of atrial high-rate episodes (AHREs) and their impact on risk of stroke. We performed a comprehensive, tabulated review of published literature on the prevalence of AHRE. In patients with AHRE, but without atrial fibrillation (AF), we reviewed the stroke risk and the potential risk/benefit of oral anticoagulation. Atrial high-rate episodes are found in 10-30% of AF-free patients. Presence of AHRE slightly increases stroke risk (0.8% to 1%/year) compared with patients without AHRE. Atrial high-rate episode of longer duration (e.g. those >24 h) could be associated with a higher stroke risk. Oral anticoagulation has the potential to reduce stroke risk in patients with AHRE but is associated with a rate of major bleeding of 2%/year. Oral anticoagulation is not effective in patients with heart failure or survivors of a stroke without AF. It remains unclear whether anticoagulation is effective and safe in patients with AHRE. Atrial high-rate episodes are common and confer a slight increase in stroke risk. There is true equipoise on the best way to reduce stroke risk in patients with AHRE. Two ongoing trials (NOAH-AFNET 6 and ARTESiA) will provide much-needed information on the effectiveness and safety of oral anticoagulation using non-vitamin K antagonist oral anticoagulants in patients with AHRE.
650    _2
$a antikoagulancia $x terapeutické užití $7 D000925
650    _2
$a fibrilace síní $x komplikace $x farmakoterapie $x epidemiologie $7 D001281
650    _2
$a celosvětové zdraví $7 D014943
650    _2
$a srdeční síně $x patofyziologie $7 D006325
650    _2
$a srdeční frekvence $x fyziologie $7 D006339
650    _2
$a lidé $7 D006801
650    _2
$a prevalence $7 D015995
650    _2
$a hodnocení rizik $x metody $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a cévní mozková příhoda $x epidemiologie $x etiologie $x prevence a kontrola $7 D020521
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Blank, Benjamin $u Atrial Fibrillation NETwork (AFNET), Muenster, Germany.
700    1_
$a Blomström-Lundqvist, Carina $u Department of Medical Science, Uppsala University, Uppsala, Sweden.
700    1_
$a Brandes, Axel $u Department of Clinical Research, University of Southern Denmark, Odense, Denmark. Department of Cardiology, Odense University Hospital, Odense, Denmark.
700    1_
$a Cabanelas, Nuno $u Arrhythmias Unit of Cardiology Department, Hospital Prof. Dr. Fernando Fonseca, Amadora-Sintra, Portugal.
700    1_
$a Dan, G-Andrei $u Colentina University Hospital, Medicine University "Carol Davila", Bucharest, Romania.
700    1_
$a Dichtl, Wolfgang $u University Hospital of Internal Medicine III, Medical University Innsbruck, Innsbruck, Austria.
700    1_
$a Goette, Andreas $u Atrial Fibrillation NETwork (AFNET), Muenster, Germany. St. Vincenz Hospital Paderborn, Cardiology and Intensive Care Medicine, Paderborn, Germany.
700    1_
$a de Groot, Joris R $u Department of Cardiology, Heart Center, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
700    1_
$a Lubinski, Andrzej $u Department of Interventional Cardiology and Arrhythmias, Medical University of Lodz, Lodz, Poland.
700    1_
$a Marijon, Eloi $u Cardiac Electrophysiology Section, European Georges Pompidou Hospital, Paris, France.
700    1_
$a Merkely, Béla $u Heart and Vascular Center, Semmelweis University Budapest, Budapest, Hungary.
700    1_
$a Mont, Lluis $u Cardiovascular Clinical Institute, Hospital Clinic, Universitat de Barcelona, Catalonia, Spain.
700    1_
$a Piorkowski, Christopher $u Herzzentrum Dresden GmbH, Universitätsklinikum, Dresden, Germany.
700    1_
$a Sarkozy, Andrea $u Universitair Ziekenhuis Antwerpen, Edegem, Belgium.
700    1_
$a Sulke, Neil $u Eastbourne District General Hospital, Eastbourne, UK.
700    1_
$a Vardas, Panos $u Heart Sector, Hygeia Group Hospitals, Athens, Greece.
700    1_
$a Velchev, Vasil $u Cardiology Clinic, St. Anna University Hospital, Medical University Sofia, Sofia, Bulgaria.
700    1_
$a Wichterle, Dan $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Kirchhof, Paulus $u Atrial Fibrillation NETwork (AFNET), Muenster, Germany. Institute of Cardiovascular Sciences, University of Birmingham, UHB and Sandwell & West Birmingham Hospitals NHS Trusts, IBR 126a, Wolfson Drive, Birmingham B15 2TT, UK.
773    0_
$w MED00149837 $t Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology $x 1532-2092 $g Roč. 21, č. 10 (2019), s. 1459-1467
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31377792 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114155155 $b ABA008
999    __
$a ok $b bmc $g 1609136 $s 1119981
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 21 $c 10 $d 1459-1467 $e 2019Oct01 $i 1532-2092 $m Europace $n Europace $x MED00149837
GRA    __
$a FS/13/43/30324 $p British Heart Foundation $2 United Kingdom
GRA    __
$a PG/17/30/32961 $p British Heart Foundation $2 United Kingdom
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace